3Ginsberg MD. Neuroprotection for ischemic stroke- past, pres- ent and future. Neuropharmacology, 2008,55 : 363 - 389.
4Sahota P, Savitz SI. Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeu- tics,2011, 8:434-451.
5Meloni BP, Campbell K, Zhu H, et al. In search of clinical neuroprotection after brain ischemia: the case for mild hypo- thermia (35 degrees C) and magnesium. Stroke, 2009, 40 : 2236 -2240.
6Prajapati KD, Sharma SS, Roy N. Current perspectives on potential role of albumin in neuroprotection. Rev Neurosci, 2011, 22 : 355 -363.
7Tang J, Li YJ, Mu J, et al. Albumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permea- bility and ischemic brain injury in rats. Neurol Res, 2009, 31 : 189 - 194.
8Ginsberg MD, Hill MD, Palesch YY, et al. The ALIAS pi- lot trial : a dose-escalation and safety study of albumin thera- py for acute ischemic stroke-I: physiological responses and safety results. Stroke, 2006, 57 : 2100 -2106.
9Palesch YY, Hill MD, Ryckborst K J, et al. The ALIAS Pi- lot Trial: a dose-escalation and safety study of albumin ther- apy for acute ischemic stroke-Ⅱ: neurologic outcome and ef- ficacy analysis. Stroke,2006, 37 : 2107 - 2114.
10Ginsberg MD, Palesch YY, Martin RH, et al. The albumin in acute stroke (ALIAS) muhicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke, 2011,42 : 119 - 127.
二级参考文献49
1del Zoppo GJ. Stroke and neurovascular protection[J]. N Engl J Med, 2006,354(6) :553 - 555.
2Green AR, Shuaib A. Therapeutic strategies for the treatment of stroke[J]. Drug Discovery Today, 2006, 11(15/ 16) :681 - 693.
5Lo EH, Turgay D, Moskowitz MA. Mechanisms, challenges, and opportunities in stroke[J]. Nat Rev of Neurosci, 2003,4(5) :399 - 416.
6Cao G, Pei W, Ge H, et al. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis[J]. J Neurosci, 2002,22(13) :5423 - 5431.
7Bruno V, Battaglia G, Copani A, et al. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs[J]. J Cereb Blood Flow Metab, 2001,21(9):1013 - 1033.
8Horn J, Limburg M. Calcium antagonists for ischemic stroke: a systematic review[J]. Stroke, 2001,32(2) :570 - 576.
9Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain[J]. J Cereb Blood Flow Metab, 2001,21(1):2- 14.
10Kroemer G, Reed JC. Mitochondrial control of cell death [J]. Nat Med, 2000,6(5) :513 - 519.
7Worp HB,Sena ES, Donnan GA, et al. Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta- analysis [ J ]. Brain, 2007,130:3063 -3074.
8Hemmen TM, Raman R, Guluma KZ, et al. Intravenous thrombolysis plus hypothermia for acute treatment of ischemie stroke ( ICTUS - L) : final results [ J ]. Stroke, 2010,41 : 2265 -2270.
9Jiang JY,Lyeth BG,Clifton GL,et al, Relationship between body and brain temperature in traumatically brain-injured rodents[ J]. Neurosurgery, 1991,74 ( 3 ) :492 -496.
10Soukup J, Zauner A, Doppenberg E, et aI. The importance of brain temperature in patients after severe traumatic brain injury: relationship to intracrauial pressure, cerebral perfusion pressure, cerebral blood flow, and outcome [ J ]. Neurotrauma, 2002, 19 (5) :559-571.
